Last reviewed · How we verify

NCT06587906

Postoperative Complications Following Skull Base Tumor Resection

Recruiting now Last updated 14 February 2025
What this trial tests

trial testing Pulmonary ultrasound examination in Skull Base Tumor in 122 participants. Currently enrolling.

Timeline
10 September 2024
Primary endpoint
1 September 2027
1 September 2027

Quick facts

Lead sponsorBeijing Tiantan Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment122
Start date10 September 2024
Primary completion1 September 2027
Estimated completion1 September 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

18 and older, any sex, with Skull Base Tumor or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The skull base tumor is located in the deep intracranial layer and is closely related to the brain stem and intracranial nerves. The incidence of postoperative complications after skull base tumor resection is high. Therefore, the perioperative management of skull base tumor resection is challenging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06587906.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing